Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. - Test2 - elhamkhani - TriplyDB

Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.

Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.

http://www.wikidata.org/entity/Q34546584

about

Unifi nootropics from the lab to the web: a story of academic (and industrial) shortcomings.Activation of a Cryptic Gene Cluster in Lysobacter enzymogenes Reveals a Module/Domain Portable Mechanism of Nonribosomal Peptide Synthetases in the Biosynthesis of Pyrrolopyrazines.

P2860

Q34469713-6EB0A3E6-877F-4776-86DB-62EE0A375EFD Q53076713-96EE95B7-121B-4A94-AB94-321DBA2DD935

P2860

Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers.

http://www.wikidata.org/entity/Q34546584

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Pharmacological characterizati ...... ew potent cognition enhancers.

@ast

Pharmacological characterizati ...... ew potent cognition enhancers.

@en

Pharmacological characterizati ...... ew potent cognition enhancers.

@nl

type

label

Pharmacological characterizati ...... ew potent cognition enhancers.

@ast

Pharmacological characterizati ...... ew potent cognition enhancers.

@en

Pharmacological characterizati ...... ew potent cognition enhancers.

@nl

prefLabel

Pharmacological characterizati ...... ew potent cognition enhancers.

@ast

Pharmacological characterizati ...... ew potent cognition enhancers.

@en

Pharmacological characterizati ...... ew potent cognition enhancers.

@nl

P1433

Q34546584-E0E734B2-E49A-4E9F-BB2F-043C6832E81D

P1476

Q34546584-2211ABEE-D1D5-4AC7-B6C7-A06B7EA2DEB9

P2093

Q34546584-0E7CFFE7-D3FC-460E-ABFE-766907035523

Q34546584-38921CC1-2274-4011-BA6B-54F64521E9A0

Q34546584-656739A9-0A68-4EF3-8A91-626C80C0E4B3

Q34546584-BF98B8E6-A1FB-4BB7-858B-EBB094443BF7

Q34546584-E978A128-810B-4C1F-AE6A-3D9F6C00F743

P2860

Q34546584-01FE8ACF-644C-4CF4-AFF9-054FF54D7364

Q34546584-094A040F-92DB-49E8-97D9-4064D6C36242

Q34546584-0D7B6542-66D6-420C-A0CB-8E1C7B992AC1

Q34546584-138D85C0-102E-42A8-B831-24795666F652

Q34546584-1B7EB13F-289B-4BD9-92D9-E37A01FCF2ED

Q34546584-25D5624B-86B0-4366-B586-45EA7D92C3CE

Q34546584-27E9471C-3C4E-4C7C-B790-D9D9A8A31C8F

Q34546584-2B8DA155-FD28-4756-A18F-ED5E17971372

Q34546584-327CFFEE-ACBB-4C4C-BC25-FB79A8EEB2B0

Q34546584-3DA6DD90-96C9-48E0-A640-BF4C09159A1F

P304

Q34546584-A4596611-8B63-4766-9EC3-8B588FE65407

P31

Q34546584-1C720129-6C9D-425A-A60D-2A4FA63782C6

P356

Q34546584-54F10BEE-4758-4142-92BD-32C652BCA5B3

P433

Q34546584-8AFAB30D-A33F-4CB2-9EC9-2F6F6C27DE7C

P478

Q34546584-5E1EB31E-9318-4680-B0FA-E41247A86169

P50

Q34546584-ADAF2B83-CB51-4C64-A8D7-A788E0BBB556

P577

Q34546584-D5BAA0B1-05CB-46AC-B72E-EA3E44DAF125

P5875

Q34546584-F9284F09-84A9-4C1F-A7FD-750E75D6B6A9

P698

Q34546584-43CC87E9-CA02-4B12-B214-9A6AB92616B9

P932

Q34546584-D23AE165-8BA4-4A4B-A809-3C9117B776D7

P356

J.1527-3458.2006.00039.X

P1433

CNS Neuroscience & Therapeutics

P1476

Pharmacological characterizati ...... new potent cognition enhancers

@en

P2093

C Ghelardini

http://www.w3.org/2001/XMLSchema#string

D Manetti

http://www.w3.org/2001/XMLSchema#string

E Martini

http://www.w3.org/2001/XMLSchema#string

F Gualtieri

http://www.w3.org/2001/XMLSchema#string

M N Romanelli

http://www.w3.org/2001/XMLSchema#string

P2860

Facilitation of glutamate receptors enhances memory

Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo

Alzheimer's disease: the cholesterol connection

Design and Study of Piracetam-like Nootropics, Controversial Members of the Problematic Class of Cognition-Enhancing Drugs

Magnesium gates glutamate-activated channels in mouse central neurones

Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.

Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity.

Structure-activity relationship studies on unifiram (DM232) and sunifiram (DM235), two novel and potent cognition enhancing drugs.

Enantioselective synthesis and preliminary pharmacological evaluation of the enantiomers of unifiram (DM232), a potent cognition-enhancing agent.

Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.

P304

39-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1527-3458.2006.00039.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Nicoletta Galeotti

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6950386

http://www.w3.org/2001/XMLSchema#string

P698

16834757

http://www.w3.org/2001/XMLSchema#string

P932

6741768

http://www.w3.org/2001/XMLSchema#string